Follow
Raphael Aruleba
Title
Cited by
Cited by
Year
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ...
The Lancet 400 (10369), 2221-2248, 2022
4952022
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ...
The Lancet 402 (10397), 203-234, 2023
3692023
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ...
The Lancet 400 (10352), 563-591, 2022
3652022
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ...
The Lancet Global Health 11 (3), e385-e413, 2023
1182023
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ...
The Lancet infectious diseases 22 (11), 1626-1647, 2022
932022
The effect of climate change and the snail-schistosome cycle in transmission and bio-control of schistosomiasis in Sub-Saharan Africa
TA Adekiya, RT Aruleba, BE Oyinloye, KO Okosun, AP Kappo
International journal of environmental research and public health 17 (1), 181, 2020
742020
Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer
RT Aruleba, TA Adekiya, BE Oyinloye, AP Kappo
International journal of molecular sciences 19 (2), 386, 2018
602018
Structure-based docking studies of GLUT4 towards exploring selected phytochemicals from Solanum xanthocarpum as a therapeutic target for the treatment of cancer
BE Oyinloye, TA Adekiya, RT Aruleba, OA Ojo, BO Ajiboye
Current drug discovery technologies 16 (4), 406-416, 2019
362019
PZQ therapy: how close are we in the development of effective alternative anti-schistosomal drugs?
RT Aruleba, TA Adekiya, BE Oyinloye, P Masamba, LS Mbatha, ...
Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2019
342019
Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach
AO Fadaka, RT Aruleba, NRS Sibuyi, A Klein, AM Madiehe, M Meyer
Journal of Biomolecular Structure and Dynamics 40 (8), 3416-3427, 2022
282022
COVID-19 diagnosis: A review of rapid antigen, RT-PCR and artificial intelligence methods
RT Aruleba, TA Adekiya, N Ayawei, G Obaido, K Aruleba, ID Mienye, ...
Bioengineering 9 (4), 153, 2022
282022
Applications of computational methods in biomedical breast cancer imaging diagnostics: a review
K Aruleba, G Obaido, B Ogbuokiri, AO Fadaka, A Klein, TA Adekiya, ...
Journal of Imaging 6 (10), 105, 2020
272020
Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation
OA Ojo, RT Aruleba, TA Adekiya, NRS Sibuyi, AB Ojo, BO Ajiboye, ...
Journal of Biomolecular Structure and Dynamics 40 (2), 848-859, 2022
242022
The practicality of the use of liquid biopsy in early diagnosis and treatment monitoring of oral cancer in resource-limited settings
HA Adeola, IO Bello, RT Aruleba, NM Francisco, TA Adekiya, AO Adefuye, ...
Cancers 14 (5), 1139, 2022
222022
Can we harness immune responses to improve drug treatment in leishmaniasis?
RT Aruleba, KC Carter, F Brombacher, R Hurdayal
Microorganisms 8 (7), 1069, 2020
222020
Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and …
OA Ojo, AA Afon, AB Ojo, BO Ajiboye, MA Okesola, RT Aruleba, ...
Journal of food biochemistry 43 (3), e12772, 2019
222019
Structural analysis and epitope prediction of MHC class-1-chain related protein-a for cancer vaccine development
TA Adekiya, RT Aruleba, S Khanyile, P Masamba, BE Oyinloye, AP Kappo
Vaccines 6 (1), 1, 2017
222017
In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis
TA Adekiya, RT Aruleba, A Klein, AO Fadaka
Journal of Biomolecular Structure and Dynamics 40 (8), 3697-3705, 2022
212022
Anti-hypercholesterolemic effect of unripe Musa paradisiaca products on hypercholesterolemia-induced rats
TA Adekiya, SA Shodehinde, RT Aruleba
Journal of Applied Pharmaceutical Science 8 (10), 090-097, 2018
212018
Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to Leishmania infection
BO Osero, RT Aruleba, F Brombacher, R Hurdayal
Cytokine: X 2 (4), 100043, 2020
172020
The system can't perform the operation now. Try again later.
Articles 1–20